Skip to content

LRMR

Larimar Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.79
−0.26%
Ask drillr
1
Insider buys (3m)
0
Insider sells (3m)
$166.9K
Net value (3m)
+3.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 8, 2026Hamilton Thomas Edward · directorPurchase50,000$3.34
May 20, 2026Truitt Joseph · directorA-Award55,150$3.33
May 20, 2026LEFF JONATHAN S · directorA-Award55,150$3.33
May 20, 2026SHERMAN JEFFREY W · directorA-Award55,150$3.33
May 20, 2026Hamilton Thomas Edward · directorA-Award55,150$3.33
May 20, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationA-Award55,150$3.33
May 20, 2026THOMAS FRANK E · directorA-Award55,150$3.33
Mar 2, 2026SHERMAN JEFFREY W · directorPurchase5,000$5.00
Mar 2, 2026Hamilton Thomas Edward · directorPurchase100,000$5.00
Mar 2, 2026THOMAS FRANK E · directorPurchase5,000$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase1,084,010$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase2,000,000$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase831,978$5.00
Mar 2, 2026Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase1,084,012$5.00
Jan 27, 2026Shankar Gopi · officer: Chief Development OfficerA-Award153,822$3.60
Jan 27, 2026BEN-MAIMON CAROLE · director, officer: President and CEOA-Award100,100$0.00
Jan 27, 2026BEN-MAIMON CAROLE · director, officer: President and CEOA-Award600,600$3.60
Jan 27, 2026Clayton Russell · officer: Chief Medical OfficerA-Award25,637$0.00
Jan 27, 2026Clayton Russell · officer: Chief Medical OfficerA-Award153,822$3.60
Jan 27, 2026Shankar Gopi · officer: Chief Development OfficerA-Award25,637$0.00
Jan 27, 2026Celano Michael · officer: Chief Financial OfficerA-Award37,604$0.00
Jan 27, 2026Celano Michael · officer: Chief Financial OfficerA-Award225,622$3.60
Aug 4, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase2,599,932$3.20
Aug 4, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase3,387,539$3.20
Aug 4, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationPurchase3,387,529$3.20
May 15, 2025Flynn James E · director, 10 percent owner, other: * Director by DeputizationA-Award19,000$1.88
May 14, 2025SHERMAN JEFFREY W · directorA-Award19,000$1.88
May 14, 2025LEFF JONATHAN S · directorA-Award19,000$1.88
May 14, 2025THOMAS FRANK E · directorA-Award19,000$1.88
May 14, 2025Hamilton Thomas Edward · directorA-Award19,000$1.88
Institutional positioning

13F filings over the trailing two quarters

New 76Increased 127Reduced 83Sold out 29
FilerActionSharesFiled
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Increased35,606,974May 15, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.Unchanged35,606,974Aug 14, 2026
Blue Owl Capital Holdings LPIncreased9,163,157Aug 11, 2026
BLUE OWL CAPITAL HOLDINGS LPReduced7,120,007May 14, 2026
BlackRock, Inc.Increased5,678,035Aug 7, 2026
BLACKROCK, INC.Increased3,752,200May 13, 2026
Defilade Capital Management, L.P.New Position3,670,135Aug 14, 2026
MILLENNIUM MANAGEMENT LLCReduced3,625,278May 15, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased3,163,423Aug 14, 2026
AIGH CAPITAL MANAGEMENT LLCIncreased3,000,000Apr 30, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,974,901Aug 13, 2026
DRIEHAUS CAPITAL MANAGEMENT LLCIncreased2,934,399May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,866,349May 15, 2026
RTW INVESTMENTS, LPIncreased2,565,999Aug 14, 2026
AQR CAPITAL MANAGEMENT LLCIncreased2,371,414Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 8, 2026